Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Assess which market exposure—Total Market or SP 500—offers more durable performance for retirement spending and resilience.
28,477 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Wells Fargo lifts its NVIDIA price target to $315 ahead of the May earnings release, maintaining an Overweight rating...
FinCEN has filed an appeal to revive a nationwide AML reporting rule for title insurers after a Texas court vacated i...
Bitcoin faces renewed pressure around the $60,000 zone with on-chain data suggesting more coins moving to exchanges. ...
Franklin Templeton has filed for two ETFs that reinvest stock dividends into Bitcoin, with an expected launch as earl...
SK Hynix's $29 billion ADR listing becomes a live test of whether the memory cycle can endure. Markets will parse dem...
A new AI-driven marketing platform is raising Reg A+ funds at $0.85 per share, pitching a fast-growth TMT play for in...
Bitcoin rebounds past $73,000 as geopolitical tensions roil markets. Analysts caution the move may be temporary, with...
A bestselling author behind Rich Dad Poor Dad signals a looming market bust and presents a crisis-era bitcoin price p...
XRP trades near $1.50 in mid-May 2026 as traders weigh a potential move to $3 this year. Regulatory clarity and liqui...
Snowflake beat estimates, raised its full-year outlook, and committed $6 billion to expand collaboration with AWS, se...
The House Ways and Means Committee plans a June hearing to decide if crypto tax relief should cover more than stablec...